- Home
- NBIX vs CLX Comparison
NBIX vs CLX Comparison
Compare NBIX & CLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | CLX |
|---|---|---|
| Founded | 1992 | 1913 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.2B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | CLX |
|---|---|---|
| Price | $155.51 | $105.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 12 |
| Target Price | ★ $173.79 | $135.42 |
| AVG Volume (30 Days) | 969.9K | ★ 2.2M |
| Earning Date | 10-28-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 4.73% |
| EPS Growth | 12.44 | ★ 121.91 |
| EPS | 4.19 | ★ 6.38 |
| Revenue | $2,682,700,000.00 | ★ $6,771,000,000.00 |
| Revenue This Year | $23.76 | N/A |
| Revenue Next Year | $18.01 | $4.85 |
| P/E Ratio | $37.10 | ★ $16.44 |
| Revenue Growth | ★ 19.61 | N/A |
| 52 Week Low | $84.23 | $98.20 |
| 52 Week High | $157.67 | $171.37 |
Technical Indicators
Market Signals| Indicator | NBIX | CLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.81 | 41.74 |
| Support Level | $150.26 | $105.00 |
| Resistance Level | $154.35 | $108.18 |
| Average True Range (ATR) | 4.16 | 2.37 |
| MACD | 1.07 | 0.69 |
| Stochastic Oscillator | 93.25 | 66.73 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CLX Clorox Company (The)
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.